Financial Performance - The net profit attributable to shareholders is expected to be between 83.55 million and 92.83 million CNY, representing a year-on-year growth of 4.28% to 15.86% compared to 80.12 million CNY in the same period last year [3] - The net profit after deducting non-recurring gains and losses is projected to be between 71.96 million and 77.84 million CNY, with a year-on-year growth of 2.09% to 10.44% compared to 70.48 million CNY last year [3] Business Strategy - The company attributes the performance improvement to a focus on product strategy, with growth in star products and the "Easy Control" series for juvenile myopia prevention [7] Financial Reporting - The financial data in this earnings forecast is preliminary and has not been audited by a registered accounting firm [7] - The specific financial data will be detailed in the company's 2024 semi-annual report [7]
明月镜片(301101) - 2024 Q2 - 季度业绩预告